Key Factors Differentiating Tolerance vs Immunosuppression to Guide Development of Precise & Antigen-Specific Therapeutic Approaches

Time: 8:30 am
day: Conference Day One


  • Understanding the specificity of current tolerance approaches to benchmark against traditional immunosuppression, drawing upon tolerance definitions from the Immune
  • Tolerance Network’s clinical trials in autoimmunity, allergy, and transplant
  • Highlighting the role of antigen-specificity and bystander tolerance in therapeutic approaches
  • Leveraging insight from the Immune Tolerance Network’s current clinical trials to induce tolerance in autoimmune diseases including multiple sclerosis, systemic sclerosis, antiphospholipid syndrome, vitiligo, and type I diabetes